Clinical Trials Directory

Trials / Unknown

UnknownNCT01609855

Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

Does Hyoscine N-butylbromide Administered During Colonoscopy Increase the Polyp Detection Rate? a Randomized, Single Center, Double Blind, Placebo-controlled Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Valduce Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary aim of the study was to test if the administration of Hyoscine Butyl Bromide, at time of caecal intubation, increases the adenoma detection rate.

Detailed description

Outpatients referred for colonoscopy were screened for possible enrollment. Exclusion criteria included: glaucoma, benign prostatic hyperplasia or urinary obstruction, previous intestinal resection, ongoing therapy with tricyclic antidepressants, chronic renal failure and history of IBD. Eligible patients were randomized to receive either 20 mg/2ml of HBB i.v. or 2ml of saline i.v.; both the endoscopist and the patient were blind to the administered drug. The endoscopist was asked to inspect the right, transverse and left colon for at least 2 min for each segment. The number, size and location of polyps were recorded as well as the occurrence episodes of tachycardia (defined as bpm\>140). As indirect estimation of the amount of air retained in the abdomen at the end of the procedure, the DAC (difference in the abdominal circumference measured before and after colonoscopy) was also calculated. At discharge (at least 1 hour after colonoscopy) the bloating perceived by the patient was measured by means of a VA scale (range 0-100).

Conditions

Interventions

TypeNameDescription
DRUGHyoscine Butyl Bromide 20mg/2 ml i.v.Hyoscine Butyl Bromide 20mg/2 ml i.v.is administered at time of caecal intubation
DRUGSaline 2 ml i.v.Administration of Saline 2 ml at time of caecal intubation

Timeline

Start date
2012-01-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-06-01
Last updated
2012-06-01

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01609855. Inclusion in this directory is not an endorsement.